Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.75 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.75 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.75 |
| ▸ | RAB9A | P51151 | 2/20 | 0.66 |
| ▸ | AGBL2 | Q5U5Z8 | 1/20 | 0.58 |
| ▸ | NPC1 | O15118 | 1/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.54 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.54 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.53 |
| ▸ | CMA1 | P23946 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.52 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29642680 | 1.00 | CYP3A4 (0.75) | CYP3A4ALDH1A1CYP1A2CYP2C19RAB9A | |
| SCHEMBL3944098 | 1.00 | CYP3A4 (0.75) | CYP3A4ALDH1A1CYP1A2CYP2C19RAB9A | |
| Hydrochloric Acid SCHEMBL8838333 | 0.98 | CYP3A4 (0.73) | CYP3A4ALDH1A1CYP1A2CYP2C19RAB9A | |
| SCHEMBL7332204 | 0.98 | CYP3A4 (0.73) | CYP3A4ALDH1A1CYP1A2CYP2C19RAB9A | |
| SCHEMBL2957608 | 0.92 | CYP3A4 (0.65) | CYP3A4ALDH1A1CYP1A2CYP2C19RAB9A | |
| Piperonylic Acid SCHEMBL3936749 | 0.91 | ALDH1A1 (0.73) | CYP3A4ALDH1A1CYP1A2CYP2C19RAB9A | |
| SCHEMBL286952 | 0.89 | ALDH1A1 (0.60) | CYP3A4ALDH1A1CYP1A2CYP2C19RAB9A | |
| SCHEMBL7148530 | 0.87 | CYP3A4 (0.72) | CYP3A4ALDH1A1CYP1A2CYP2C19RAB9A | |
| SCHEMBL13802498 | 0.86 | RAB9A (0.63) | CYP3A4ALDH1A1CYP1A2CYP2C19RAB9A | |
| SCHEMBL31114377 | 0.86 | CYP3A4 (1.00) | CYP3A4ALDH1A1CYP1A2CYP2C19RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 956 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12593844-B2 | Method and compounds to induce plant tolerance against arthropod pests | VIB VZW (BE) | 2026-04-07 | — | — | US | claimed |
| CN-115073485-B | 3-aryl-7, 8-pyranocoumarin derivative, and preparation method and application thereof | 广西中医药大学 | 2024-02-23 | — | — | CN | claimed |
| CN-114989131-B | N' - (2- (benzo [1,3] dioxolan-5-yl) acyl) aryl hydrazide compound as well as synthesis and application thereof | 云南大学 | 2023-10-24 | — | — | CN | claimed |
| CN-115215879-B | 3-aryl-4, 5-pyranocoumarin derivative, and preparation method and application thereof | 广西中医药大学 | 2023-10-20 | — | — | CN | claimed |
| CN-116444477-A | Preparation method and application of bromopiperonyl carboxylic acid | 宁波九胜创新医药科技有限公司 | 2023-07-18 | — | — | CN | claimed |
| CN-116120271-A | Genipin derivative and preparation method and application thereof | 广东工业大学 | 2023-05-16 | — | — | CN | claimed |
| CN-115215879-A | 3-aryl-4, 5-pyranocoumarin derivatives, and preparation method and application thereof | 广西中医药大学 | 2022-10-21 | — | — | CN | claimed |
| CN-115073485-A | 3-aryl-7, 8-pyranocoumarin derivatives, and preparation method and application thereof | 广西中医药大学 | 2022-09-20 | — | — | CN | claimed |
| CN-108586178-B | Process for the manufacture of nitriles and their corresponding amines | 中国石油化工股份有限公司 | 2022-02-11 | — | — | CN | claimed |
| US-20220039382-A1 | METHOD AND COMPOUNDS TO INDUCE PLANT TOLERANCE AGAINST ARTHROPOD PESTS | UNIVERSITEIT GENT (BE) | 2022-02-10 | — | — | US | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
| WO-2003057896-A1 | METHODS FOR PREPARING ANTHRACYCLINONE DERIVATIVES AND ANTHRACYCLINONE DERIVATIVES PER SE | ALBANY MOLECULAR RESEARCH, INC. (US) | 2003-07-17 | — | — | WO | claimed |
| US-20030082830-A1 | Synthesis of combinatorial libraries of compounds reminiscent of natural products | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-05-01 | — | — | US | claimed |
| US-6448443-B1 | GENERATED FROM DIVERSIFIABLE SCAFFOLDS SYNTHESIZED FROM THE PYRIDINE-BASED TEMPLATE ISONICOTINAMIDE; ALSO PROVIDES A NOVEL ORTHO-NITROBENZYL PHOTOLINKER; SYNTHESIZED FROM A SHIKIMIC ACID BASED EPOXYOL TEMPLATE | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2002-09-10 | — | — | US | claimed |
| WO-2000006525-A2 | SYNTHESIS OF COMBINATORIAL LIBRARIES OF COMPOUNDS REMINISCENT OF NATURAL PRODUCTS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2000-02-10 | — | — | WO | claimed |
| EP-0954596-A1 | ENHANCED PRODUCTION OF TAXANES BY CELL CULTURES OF $i(TAXUS) SPECIES | PHYTON, INC. (US) | 1999-11-10 | — | — | EP | claimed |
| WO-1997044476-A1 | ENHANCED PRODUCTION OF TAXANES BY CELL CULTURES OF TAXUS SPECIES | PHYTON, INC. (US) | 1997-11-27 | — | — | WO | claimed |
| US-5691373-A | TREATING SUBARACHNOID HEMORRHAGE | WARNER-LAMBERT COMPANY (US) | 1997-11-25 | — | — | US | claimed |
| EP-0714391-A1 | SUBSTITUTED 2(5H)FURANONE, 2(5H)THIOPHENONE AND 2(5H)PYRROLONE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ENDOTHELIN ANTAGONISTS | WARNER-LAMBERT COMPANY (US) | 1996-06-05 | — | — | EP | claimed |
| WO-1995005376-A1 | SUBSTITUTED 2(5H)FURANONE, 2(5H)THIOPHENONE AND 2(5H)PYRROLONE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ENDOTHELIN ANTAGONISTS | WARNER-LAMBERT COMPANY (US) | 1995-02-23 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12593844-B2 | Method and compounds to induce plant tolerance against arthropod pests | HPD, PAH, P4HTM | CYP3A4 522/4885ALDH1A1 1039/4885CYP1A2 754/4885 |
| US-20220039382-A1 | METHOD AND COMPOUNDS TO INDUCE PLANT TOLERANCE AGAINST ARTHROPOD PESTS | BROX, DDT, CAT | CYP3A4 2114/4885ALDH1A1 3206/4885CYP1A2 1511/4885 |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | CYP3A4 548/4885ALDH1A1 1723/4885CYP1A2 968/4885 |
| US-20030082830-A1 | Synthesis of combinatorial libraries of compounds reminiscent of natural products | TKFC, NISCH, PTGIS | CYP3A4 796/4885ALDH1A1 568/4885CYP1A2 312/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.